Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Completed

• Conditions: Ocular Surface Disease; Palpebral Pathologies; Meibomian Gland Dysfunction

• Registration Number: NCT01552174
• Lead Sponsor: Laboratoires Thea

Brief Summary

The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03
• Study First Submitted: 2012-03-06
• Study First Submitted QC: 2012-03-08
• Study First Posted: 2012-03-13
• Primary Completion: 2014-04
• Study Completion: 2014-04
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-31
• Last Update Posted: 2015-09-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 185

Inclusion Criteria

• Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
• Patients informed of the objectives of the survey and agreeing to participate.
• Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of eyelid disorders in general ophthalmological practice	Day 1	* Systematic description of the eyelid, the ocular surface and the dermatological aspect of the face; * Occurrence of Meibomian Gland Dysfunction(MGD).

Secondary Outcome Measures

Name	Time	Method
Impact of eyelid disorder on patient's daily life	Day 1	Consequences on vision, on daily life activities/work, on leisure, on contact lens wearing, on emotions, on sleeping,
Association between palpebral pathologies and ocular surface pathologies	Day 1	To describe association between palpebral pathologies and ocular surface pathologies
Current recommended strategy to treat eyelids disorders	Day 1	Description of recommended strategy

Trial Locations

Locations (2)

Consultation office; 🇩🇪 Heidelberg, Germany

USIO Departamento de Oftalmologia Hospital Clínico San Carlos; 🇪🇸 Madrid, Spain